Roger G. Ulrich

机构：Acerta Pharma BV (Netherlands)

发表论文 139 篇 · 总被引 9293 次 · h-index 44

代表论文

• Mapping the Genetic Architecture of Gene Expression in Human Liver (2008 · PLoS Biology · 被引 934)
• CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability (2010 · Blood · 被引 723)
• Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia (2014 · Blood · 被引 589)
• Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile (2017 · Journal of Pharmacology and Experimental Therapeutics · 被引 387)
• Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver (2010 · Genome Research · 被引 277)
• Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition (2006 · Xenobiotica · 被引 270)